Credit: Fred Hutch News Service
Dr. Stanley Riddell, an immunotherapy researcher and oncologist at Seattle’s Fred Hutchinson Cancer Research Center, presented an update on new adoptive T-cell strategies at the annual meeting of the American Association for the Advancement of Science in Washington, D.C. His presentation was part of a symposium on the promise and progress of T-cell therapy to fight human diseases. For more than 25 years, Riddell has pioneered experimental therapies that modify and empower the immune system to effectively treat cancers and infectious diseases.